Veeva Systems Inc. (NYSE:VEEV) Shares Purchased by International Assets Investment Management LLC

International Assets Investment Management LLC grew its stake in Veeva Systems Inc. (NYSE:VEEV) by 16,580.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 187,322 shares of the technology company’s stock after acquiring an additional 186,199 shares during the quarter. International Assets Investment Management LLC owned about 0.12% of Veeva Systems worth $36,063,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Wellington Management Group LLP raised its holdings in Veeva Systems by 9.6% in the 3rd quarter. Wellington Management Group LLP now owns 3,315,304 shares of the technology company’s stock valued at $674,499,000 after acquiring an additional 289,133 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its position in Veeva Systems by 34.3% during the third quarter. Massachusetts Financial Services Co. MA now owns 2,045,414 shares of the technology company’s stock worth $416,139,000 after buying an additional 522,257 shares during the period. FMR LLC boosted its stake in Veeva Systems by 15.4% in the 3rd quarter. FMR LLC now owns 1,833,135 shares of the technology company’s stock worth $372,951,000 after buying an additional 244,599 shares during the last quarter. Blair William & Co. IL grew its holdings in Veeva Systems by 0.9% in the 3rd quarter. Blair William & Co. IL now owns 1,466,121 shares of the technology company’s stock valued at $298,282,000 after buying an additional 12,709 shares during the period. Finally, Van ECK Associates Corp increased its stake in shares of Veeva Systems by 4.1% during the 3rd quarter. Van ECK Associates Corp now owns 1,447,403 shares of the technology company’s stock valued at $294,474,000 after acquiring an additional 57,520 shares during the last quarter. 88.20% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms recently issued reports on VEEV. Stifel Nicolaus boosted their target price on shares of Veeva Systems from $205.00 to $250.00 and gave the company a “buy” rating in a report on Friday, March 1st. Robert W. Baird increased their target price on Veeva Systems from $245.00 to $251.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st. Barclays lifted their target price on Veeva Systems from $240.00 to $245.00 and gave the company an “overweight” rating in a report on Friday, March 1st. JPMorgan Chase & Co. upped their price target on Veeva Systems from $183.00 to $222.00 and gave the stock a “neutral” rating in a research note on Wednesday, March 13th. Finally, Raymond James restated an “outperform” rating and issued a $260.00 price target on shares of Veeva Systems in a report on Tuesday, March 26th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $234.90.

Veeva Systems Trading Up 1.0 %

Shares of NYSE:VEEV opened at $203.49 on Friday. Veeva Systems Inc. has a 12-month low of $160.21 and a 12-month high of $236.90. The firm has a market cap of $32.83 billion, a PE ratio of 63.18, a price-to-earnings-growth ratio of 2.01 and a beta of 0.76. The company has a fifty day simple moving average of $217.75 and a 200 day simple moving average of $202.20.

Veeva Systems (NYSE:VEEV) last issued its earnings results on Thursday, February 29th. The technology company reported $0.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.81 by $0.11. The business had revenue of $630.62 million for the quarter, compared to analyst estimates of $620.75 million. Veeva Systems had a net margin of 22.24% and a return on equity of 11.26%. As a group, equities research analysts forecast that Veeva Systems Inc. will post 4.11 EPS for the current fiscal year.

Insider Transactions at Veeva Systems

In other Veeva Systems news, EVP Alan Mateo sold 3,391 shares of Veeva Systems stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $200.86, for a total value of $681,116.26. Following the completion of the transaction, the executive vice president now owns 21,983 shares of the company’s stock, valued at $4,415,505.38. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, Director Timothy S. Cabral sold 15,000 shares of the business’s stock in a transaction that occurred on Thursday, March 7th. The stock was sold at an average price of $226.04, for a total transaction of $3,390,600.00. Following the completion of the transaction, the director now owns 23,391 shares in the company, valued at approximately $5,287,301.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Alan Mateo sold 3,391 shares of the stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $200.86, for a total value of $681,116.26. Following the completion of the sale, the executive vice president now directly owns 21,983 shares in the company, valued at $4,415,505.38. The disclosure for this sale can be found here. In the last quarter, insiders sold 21,989 shares of company stock worth $4,818,013. 10.98% of the stock is currently owned by corporate insiders.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.